Cybin Inc. is a biopharmaceutical company that focuses only on mental health patients by creating safe and effective psychedelic-based therapeutics.
So, this article gives you a detailed explanation of the core business of this company, past performance, and stock records and discusses the overall influencing factors of the stock price forecast from 2025 to 2040 of this company.
Contents
About the Cybin Inc. (NYSEAMERICAN: CYBN)
Cybin Inc. develops many types of psychedelic-based compounds for patients who struggle with different types of mental disorders such as anxiety disorder, depressive disorder, and some types of addictions.
Currently, Cybin Inc. developing CYB003 which is a proprietary deuterated psilocybin analog that works for major depressive disorder. So, I mean to say that the company continuously upgrades its products and works the develop new and the most helpful products.
For the overview of its stock, you can see the table below-
| Realty Income Corp Overview | |
| Details | Information |
| Stock Name | Cybin Inc. |
| Stock Symbol | CYBN |
| Stock Exchange | NYSEAMERICAN |
| Market Cap | 2.74M USD |
| Founder | Paul Glavine, Eric So, and John Kanakis |
| Founded Year | 2019 |
| Headquarter | Toronto, Ontario Canada |
CYBN Stock Price History
CYBN stock was listed on the New York Stock Exchange on Sep 13, 2019, under the symbol of CYBN. This stock starts from $49.64. After one year of listing or during the COVID-19 pandemic, this stock touched its historical and maximum stock price which was $115.90 in June 2020.
But after this historical price, CYBN never even reached that price. Currently, this stock is traded at $9.63 per share which has decreased from 1000% approx from its historical price.
| Time | Per Share Value (USD) |
| Before 5D | $9.32 |
| Before 1M | $7.60 |
| Before 6M | $14.09 |
| Before 1Y | $21.90 |
| Before 5Y | $13.51 |
| All time Max | $115.90 |
Fundamentals of Cybin Inc. Stock
The average volume of this stock is 228.97K and the return on equity is -49.07%. Will this stock rise again or not? this question comes into all investor’s minds so for the answers to this question you have to read this complete article.
| Day Range | $9.54 – $9.80 |
| 52 Week Range | $6.50 – $28.04 |
| Avg Volume | 228.97K |
| Revenue Growth % (Yearly) | – |
| Net Income | -14.28M |
| Earning Per Share | -0.76 |
| ROE | -49.07% |
| P/B Ratio | 0.89 |
| P/E Ratio | – |
| Dividend Yield | – |
| Total Equity | 279.83M |
| Total Assets | 284.65M |
| EBITDA Margin | -20.27M |
CYBN Stock Forecast for Upcoming 1, 3, 5, 7, and 10 Years
CYBN stock forecast for the upcoming 1 to 10 ten years is shown on the table after analyzing this stock fundamentally and technically.
After one year this stock may hit $15.50 and after 10 years this stock can be touched at $15.80. So you can see nothing of a big difference in this growth from 1 to 10 years because of its clinical trial failure and weak fundamentals.
| Year | Minimum Price Prediction | Maximum Price Prediction |
| 1 Year | $8.50 | $15.50 |
| 2 Year | $10.57 | $12.85 |
| 3 Year | $ 8.95 | $11.78 |
| 4 Year | $ 8.40 | $10.80 |
| 5 Year | $7.59 | $9.67 |
| 6 Year | $ 6.95 | $8.78 |
| 7 Year | $ 6.25 | $7.50 |
| 8 Year | $7.20 | $6.95 |
| 9 Year | $ 4.80 | $5.87 |
| 10 Year | $ 12.68 | $15.80 |
CYBN Stock Forecast 2025
CYBN stock forecast for 2025 is expected to touch $15.50 at the end of the year and start from $8.50. However, Cybin is continuously facing loss but despite this, not stock these clinical trials. Currently, the trial of this company is carry on CYB003.
| Year | 2025 |
| Minimum Price Prediction | $8.50 |
| Maximum Price Prediction | $15.50 |
CYBN Stock Forecast 2026
Cybin stock price prediction for 2026 will be between $10.57 to $12.85 per share. According to this prediction, the company will gain +20% for the upcoming 2 years.
| Year | 2026 |
| Minimum Price Prediction | $10.57 |
| Maximum Price Prediction | $12.85 |
CYBN Stock Forecast 2027
There are some faults in the business model of this company because if it maintains its previous trends then this stock will not gain in any percentage in the future.
| Year | 2027 |
| Minimum Price Prediction | $8.95 |
| Maximum Price Prediction | $11.78 |
CYBN Stock Forecast 2030
Cybin stock forecast for 2030 is expected to be $6.25 in the first 6 months of this year and this stock hit $7.50 in the next half-yearly of this stock.
| Year | 2030 |
| Minimum Price Prediction | $6.25 |
| Maximum Price Prediction | $7.50 |
CYBN Stock Forecast 2035
After seeing the present condition of this company this stock does not perform well in the share market. The stock price forecast and prediction for 2035 is estimated to be $4.80 to $5.87 per share.
| Year | 2035 |
| Minimum Price Prediction | $4.80 |
| Maximum Price Prediction | $5.87 |
CYBN Stock Forecast 2040
CYBN stock forecast for 2040 will be expected to be $12.68 to $15.80 per share from the start to the end of the year. If compare this growth from the start of the stock then it’s decreasing from -1000%.
| Year | 2040 |
| Minimum Price Prediction | $12.68 |
| Maximum Price Prediction | $15.80 |
CYBN Stock Forecast 2025, 2026 to 2040
If you see the prediction chart for this company, then it a subject to huge volatility but according to this forecast chart, CYBN stock growth will be almost zero in upcoming the year 2040.
| Year | Minimum Price Prediction | Maximum Price Prediction |
| 2024 | $8.50 | $15.50 |
| 2025 | $10.57 | $12.85 |
| 2026 | $ 8.95 | $11.78 |
| 2027 | $ 8.40 | $10.80 |
| 2028 | $7.59 | $9.67 |
| 2029 | $ 6.95 | $8.78 |
| 2030 | $ 6.25 | $7.50 |
| 2031 | $7.20 | $6.95 |
| 2035 | $ 4.80 | $5.87 |
| 2040 | $ 12.68 | $15.80 |
Financial Chart of CYBN Stock–Annual
From the year 2020, this company continuously faces a big amount of losses in the net income which you can see clearly in the chart below. The net income of this company was -1.94M in 2020 but now the net income is a big loss -78.08M.
| Year | Revenue | Net Income | Total Assets |
| 2020 | – | -1.94M | 1.71M |
| 2021 | 864.00K | -32.22M | 92.11M |
| 2022 | – | -67.63M | 84.06M |
| 2023 | – | -47.49M | 53.90M |
| 2024 | – | -78.08M | 302.02M |
Deep Track Capital LPÂ and RA Capital Management LPÂ are the largest shareholders of this company which holds the same amount of shares which is 7.653%. The third largest shareholder of this stock is 5.265%.
| Shareholder | Equity % |
| Deep Track Capital LP | 7.653 |
| RA Capital Management LP | 7.653 |
| Logos Global Management LP | 5.265 |
FAQs
What does Cybin Inc. (CYBN) do?
Cybin Inc. is a biopharmaceutical company that’s developing psychedelic-based therapeutics.
Is CYBN a good stock to buy?
The future growth of this stock depends on maintenance and leads the market of psychedelic therapies. If the future clinical trials of this stock are successful then Cybin stock can become good stock for the buyers.
What is the forecast for CYBN stock by 2025?
The forecast of CYBN stock for 2025 is expected to be $10.57 to $12.85 per share.
What are the key risks of investing in CYBN stock?
The major risk of this stock is if clinical trials will fail then this stock not perform well in the stock market and another risk is psychedelic space is too competitive.
What is the long-term stock forecast for Cybin?
The long-term stock forecast of Cybin will expect $ 12.68 to $15.80 for 2040.
Conclusion
If you are thinking about investing in this stock, then you have to wait right now because CYBN stock has been continuously down for the last few years. However, the company focuses on innovative psychedelic therapies and revolutionizes them for mental disorder patients. So, for long-term investments, you can go through with this stock.